Efficacy of Madhav Rasayan Plus as adjuvant in moderate COVID-19 patients: Preliminary outcomes of randomized controlled trial
Apart from all the gloominess, the COVID-19 Pandemic has a silver lining of bringing a renaissance as Ayurveda and integrated medicine are becoming a choice for acute as well as infective diseases. Here we report outcomes of a preliminary work, the randomized controlled trial (CTRI/2021/02/031256) o...
Główni autorzy: | Sameer Jamadagni, Prasad Pandkar, Tushar Saundankar, Girish Shirke, Shailesh Malekar, V.G. Vaidya |
---|---|
Format: | Artykuł |
Język: | English |
Wydane: |
Elsevier
2022-07-01
|
Seria: | Journal of Ayurveda and Integrative Medicine |
Hasła przedmiotowe: | |
Dostęp online: | http://www.sciencedirect.com/science/article/pii/S0975947622000493 |
Podobne zapisy
-
Ayurvedic lipid based rasayans - A perspective on the preparation and pharmacological significance of lipids on the bioavailability of phytoconstituents
od: Sharadendu Bali, i wsp.
Wydane: (2022-04-01) -
Evaluation of Comparative Efficacy of Ashwagandha (Withania somnifera) vs Brahmi (Bacopa monnieri Linn) on Stress Level and Quality of Sleep in the Subjects Experiencing Mental Stress: A Clinical Trial Protocol
od: Mohnish Vijay Gokhale, i wsp.
Wydane: (2025-01-01) -
Vidyarthimitra Vaidya Madhav Vasudev Kolhatkar
od: Vaidya Dilip Gadgil
Wydane: (2012-01-01) -
Sweet syndrome unresponsive to corticosteroid therapy managed with ayurveda medication: A case report
od: Ashok Kumar Panda, i wsp.
Wydane: (2023-05-01) -
Effect of Puta on in vitro anticancer activity of Shataputi Abhrak Bhasma on lung, leukemia and prostate cancer cell lines
od: Yogesh L. Tamhankar, i wsp.
Wydane: (2020-04-01)